Cargando…

Mitochondrial dysfunction in Parkinsonian mesenchymal stem cells impairs differentiation

Sporadic cases account for 90–95% of all patients with Parkinson's Disease (PD). Atypical Parkinsonism comprises approximately 20% of all patients with parkinsonism. Progressive Supranuclear Palsy (PSP) belongs to the atypical parkinsonian diseases and is histopathologically classified as a tau...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angelova, Plamena R., Barilani, Mario, Lovejoy, Christopher, Dossena, Marta, Viganò, Mariele, Seresini, Agostino, Piga, Daniela, Gandhi, Sonia, Pezzoli, Gianni, Abramov, Andrey Y., Lazzari, Lorenza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680522/ https://www.ncbi.nlm.nih.gov/pubmed/29096320 http://dx.doi.org/10.1016/j.redox.2017.10.016

Ejemplares similares

NG2 as an Identity and Quality Marker of Mesenchymal Stem Cell Extracellular Vesicles
por: Barilani, Mario, et al.
Publicado: (2019)

Autologous mesenchymal stem cell therapy for progressive supranuclear palsy: translation into a phase I controlled, randomized clinical study
por: Giordano, Rosaria, et al.
Publicado: (2014)

Microtubule defects in mesenchymal stromal cells distinguish patients with Progressive Supranuclear Palsy
por: Calogero, Alessandra Maria, et al.
Publicado: (2018)

Hyperammonaemia induces mitochondrial dysfunction and neuronal cell death
por: Angelova, Plamena R., et al.
Publicado: (2022)

What is beyond a qRT-PCR study on mesenchymal stem cell differentiation properties: how to choose the most reliable housekeeping genes
por: Ragni, Enrico, et al.
Publicado: (2013)

Lipid peroxidation is essential for α‐synuclein‐induced cell death
por: Angelova, Plamena R., et al.
Publicado: (2015)

Changes in the proteomic profile of adipose tissue-derived mesenchymal stem cells during passages
por: Capra, Emanuele, et al.
Publicado: (2012)

Finding a new therapeutic approach for no-option Parkinsonisms: mesenchymal stromal cells for progressive supranuclear palsy
por: Canesi, Margherita, et al.
Publicado: (2016)

Carbon monoxide neurotoxicity is triggered by oxidative stress induced by ROS production from three distinct cellular sources
por: Angelova, Plamena R., et al.
Publicado: (2023)

Inorganic polyphosphate is produced and hydrolyzed in F(0)F(1)-ATP synthase of mammalian mitochondria
por: Baev, Artyom Y., et al.
Publicado: (2020)

Standardized GMP-compliant scalable production of human pancreas organoids
por: Dossena, Marta, et al.
Publicado: (2020)

Central metabolism of functionally heterogeneous mesenchymal stromal cells
por: Barilani, Mario, et al.
Publicado: (2019)

Tips and Tricks for Validation of Quality Control Analytical Methods in Good Manufacturing Practice Mesenchymal Stromal Cell Production
por: Viganò, Mariele, et al.
Publicado: (2018)

Polyhydroxybutyrate Targets Mammalian Mitochondria and Increases Permeability of Plasmalemmal and Mitochondrial Membranes
por: Elustondo, Pia A., et al.
Publicado: (2013)

Differences in Muscle Strength in Parkinsonian Patients Affected on the Right and Left Side
por: Frazzitta, Giuseppe, et al.
Publicado: (2015)

Intensive Rehabilitation Treatment in Parkinsonian Patients with Dyskinesias: A Preliminary Study with 6-Month Followup
por: Frazzitta, Giuseppe, et al.
Publicado: (2012)

Autonomic Dysfunctions in Parkinsonian Disorders
por: Bae, Hyo-Jin, et al.
Publicado: (2009)

Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction
por: Kinghorn, Kerri J., et al.
Publicado: (2015)

Nrf2 regulates ROS production by mitochondria and NADPH oxidase
por: Kovac, Stjepana, et al.
Publicado: (2015)

Activation of RAGE leads to the release of glutamate from astrocytes and stimulates calcium signal in neurons
por: Kamynina, Anna, et al.
Publicado: (2021)

FGF23 and Fetuin-A Interaction and Mesenchymal Osteogenic Transformation
por: Mattinzoli, Deborah, et al.
Publicado: (2019)

Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes
por: Indrieri, Alessia, et al.
Publicado: (2020)

Impaired reach-to-grasp kinematics in parkinsonian patients relates to dopamine-dependent, subthalamic beta bursts
por: Vissani, Matteo, et al.
Publicado: (2021)

Critical Analysis of cGMP Large-Scale Expansion Process in Bioreactors of Human Induced Pluripotent Stem Cells in the Framework of Quality by Design
por: Rivera-Ordaz, Araceli, et al.
Publicado: (2021)

Signal transduction in astrocytes: Localization and release of inorganic polyphosphate
por: Angelova, Plamena R., et al.
Publicado: (2018)

iPSC-derived neuronal models of PANK2-associated neurodegeneration reveal mitochondrial dysfunction contributing to early disease
por: Arber, Charles, et al.
Publicado: (2017)

Chondrogenic and BMP-4 primings confer osteogenesis potential to human cord blood mesenchymal stromal cells delivered with biphasic calcium phosphate ceramics
por: Brennan, Meadhbh Á., et al.
Publicado: (2021)

RT001 in Progressive Supranuclear Palsy—Clinical and In-Vitro Observations
por: Angelova, Plamena R., et al.
Publicado: (2021)

Ca(2+) is a key factor in α-synuclein-induced neurotoxicity
por: Angelova, Plamena R., et al.
Publicado: (2016)

Pharmacological Sequestration of Mitochondrial Calcium Uptake Protects Neurons Against Glutamate Excitotoxicity
por: Angelova, Plamena R., et al.
Publicado: (2018)

Low-affinity Nerve Growth Factor Receptor (CD271) Heterogeneous Expression in Adult and Fetal Mesenchymal Stromal Cells
por: Barilani, Mario, et al.
Publicado: (2018)

How we make cell therapy in Italy
por: Montemurro, Tiziana, et al.
Publicado: (2015)

Validation of an automated cell counting method for cGMP manufacturing of human induced pluripotent stem cells
por: Manzini, Paolo, et al.
Publicado: (2022)

Short- and Long-Term Efficacy of Intensive Rehabilitation Treatment on Balance and Gait in Parkinsonian Patients: A Preliminary Study with a 1-Year Followup
por: Frazzitta, Giuseppe, et al.
Publicado: (2013)

Diet with LPP for renal patients increases daily energy expenditure and improves motor function in Parkinsonian patients with motor fluctuations
por: Barichella, Michela, et al.
Publicado: (2007)

Different Dopaminergic Dysfunctions Underlying Parkinsonian Akinesia and Tremor
por: Caligiore, Daniele, et al.
Publicado: (2019)

β-Naphthoflavone and Ethanol Reverse Mitochondrial Dysfunction in A Parkinsonian Model of Neurodegeneration
por: Fernandez-Abascal, Jesus, et al.
Publicado: (2020)

Mechanism of Oxidative Stress in Neurodegeneration
por: Gandhi, Sonia, et al.
Publicado: (2012)

Safety and Effectiveness of Cell Therapy in Neurodegenerative Diseases: Take-Home Messages From a Pilot Feasibility Phase I Study of Progressive Supranuclear Palsy
por: Giordano, Rosaria, et al.
Publicado: (2021)

FOXP1 circular RNA sustains mesenchymal stem cell identity via microRNA inhibition
por: Cherubini, Alessandro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pn3j03kn0mfne92jq2a0ocp9de